Last time we looked, Turing Pharmaceutical honcho Martin Shkreli was busy reneging on his company's promise to drastically reduce the cost of its flagship med Daraprim.
But that was then, and this is now:
"Martin Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fiftyfold, was arrested Thursday on securities fraud charges unrelated to the furor."
Sure, they say it's not related to the Daraprim kerfluffle, but it certainly reflects a, shall we say, blase attitude towards ethical behavior that seems to permeate his business dealings.
Of course, he's innocent until proven guilty, but who's really taking the over/under on that?
So long, Marty!
But that was then, and this is now:
"Martin Shkreli, the former hedge fund manager vilified in nearly every corner of America for buying a pharmaceutical company and jacking up the price of a life-saving drug more than fiftyfold, was arrested Thursday on securities fraud charges unrelated to the furor."
Sure, they say it's not related to the Daraprim kerfluffle, but it certainly reflects a, shall we say, blase attitude towards ethical behavior that seems to permeate his business dealings.
Of course, he's innocent until proven guilty, but who's really taking the over/under on that?
So long, Marty!